SeaCrest Wealth Management’s AIM ImmunoTech AIM Stock Holding History
Bought
Maintained
Sold
Other funds holding AIM
CB
HI
HI
DB
SeaCrest Wealth Management's AIM Position: Q2 2025 in Review
SeaCrest Wealth Management sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 351 shares — an estimated $4.29K sold.
SeaCrest Wealth Management first reported a position in AIM in Q2 2020 and held it in 20 quarters. The position peaked at $115K in Q2 2020. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.
- SeaCrest Wealth Management reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
- SeaCrest Wealth Management sold 351 AIM ImmunoTech shares in Q2 2025, an estimated $4.29K.
- SeaCrest Wealth Management first reported a position in AIM ImmunoTech in Q2 2020 and held it in 20 quarters.
- SeaCrest Wealth Management's AIM ImmunoTech position peaked at $115K in Q2 2020.
- 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.
Based on SeaCrest Wealth Management's 13F filing for Q2 2025, filed 11 Jul 2025.